G1 Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.614; its P/E ratio is -5.37; G1 Therapeutics is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 14.87M	$ 12.30M	$ 42.39M	$ 12.95M	$ 10.25M
Gross Profit	$ 13.62M	$ 12.30M	$ 42.39M	$ 12.95M	$ 10.25M
EBIT	$ -7.85M	$ -17.30M	$ 10.02M	$ -27.59M	$ -33.17M
EBITDA	$ -7.73M	$ -17.47M	$ 9.86M	$ -27.43M	-
Net Income Common Stockholders	$ -10.88M	$ -18.20M	$ 8.71M	$ -27.59M	$ -33.65M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 82.16M	$ 94.35M	$ 104.29M	$ 116.38M	$ 145.13M
Total Assets	$ 121.54M	$ 133.10M	$ 147.89M	$ 161.96M	$ 187.97M
Total Debt	$ 55.90M	$ 55.92M	$ 55.93M	$ 82.78M	$ 82.63M
Net Debt	$ -26.26M	$ -38.43M	$ -48.36M	$ -33.60M	$ -62.50M
Total Liabilities	$ 86.15M	$ 90.08M	$ 90.34M	$ 116.97M	$ 187.98M
Stockholders Equity	$ 35.39M	$ 43.02M	$ 57.55M	$ 44.99M	$ 68.77M
Cash Flow	-
Free Cash Flow	$ -12.79M	$ -10.58M	$ 14.09M	$ -29.05M	$ -30.63M
Operating Cash Flow	$ -12.79M	$ -10.58M	$ 14.09M	$ -29.05M	$ -30.63M
Investing Cash Flow	$ -7.65M	$ 7.20M	$ 346.00K	$ 2.91M	$ -20.36M
Financing Cash Flow	$ 34.00K	$ 22.00K	$ -26.75M	$ -214.00K	$ 52.35M

Currency in USD

G1 Therapeutics Earnings and Revenue History

Income Statement >

G1 Therapeutics Debt to Assets

Balance Sheet >

G1 Therapeutics Cash Flow

Cash Flow >

G1 Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing